U.S.-based pharmaceutical major Eli Lilly and Co. $LLY has entered into a definitive agreement to acquire Verve Therapeutics Inc. $VERV, a clinical-stage biotech innovator focused on gene-editing ther...

Novo Nordisk A/S $NOVO-B.CO has overtaken SAP SE $SAP to regain its position as the most valuable publicly traded company in Europe. The Danish pharmaceutical giant's market capitalization rose to $36...

Novo Nordisk $NOVO-B.CO, the Danish pharmaceutical giant behind the blockbuster weight-loss drug Wegovy, announced on Thursday its plan to begin late-stage clinical trials for both injectable and oral...

Metsera Inc. $MTSR, a biotech startup targeting obesity, saw a sharp rally in its stock after releasing positive early-stage trial data for its experimental weight-loss therapy, MET-233i. According to...

Eli Lilly & Co. $LLY, a prominent name in the pharmaceutical industry, has witnessed a remarkable increase in sales for its weight-loss and diabetes medication, Mounjaro, within the Indian market. The...

The global pharmaceutical landscape is undergoing a pivotal transformation as obesity treatment surges to the forefront of healthcare innovation. One of the central players in this shift, Novo Nordisk...